Possible therapies for the overexpressed kinases include CDK4/CDK6 inhibitors, such as Palbociclib, which has been shown effective in human liver cancer cell lines and mouse models with intact tumor suppressor Retinoblastoma (Rb1) (34). This evidence concerns the gene CDK6 and liver cancer.